Beleodaq Lyophilisate For Solution For Injection 500Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Beleodaq: Lyophilisate for solution for injection (500mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BELINOSTAT (beh-LIH-noh-STAT) is a chemotherapy drug. It is used to treat peripheral T-cell lymphoma.

In-Depth Information

Beleodaq 500mg Powder for Injection

NDC: 681520108
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Peripheral T-cell Lymphoma (PTCL)

Storage Information
Use within 12 hours after reconstitution
Store in original package until time of use
Discard product if it contains particulate matter, is cloudy, or discolored
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Beleodaq 500mg Powder for Injection

Reported Side Effects for Beleodaq 500mg Powder for Injection

Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Tumor Lysis Syndrome (TLS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Skin Rash Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Irritated Blood Vessels Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Chills Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Vomiting Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Infection Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Constipation Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
>2.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Loose Stools Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Itching Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Low Blood Pressure Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Low Potassium Levels Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Long Qt Syndrome Incidence:
4.0%*
Severity: SEVERE
Onset: RAPID
Tired Incidence:
5.0%*
Severity: SEVERE
Onset: EARLY
Shortness Of Breath Incidence:
6.0%*
Severity: SEVERE
Onset: EARLY
Low Platelet Count Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
11.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
15.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
19.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
20.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Beleodaq

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5